ET
Esanik Therapeutics, Inc.
SEC filingPharmaceuticals · Northville, MI
Amount raised$200Ksold at filing
Total offering$375K$175K still open
Investors in the raise1count reported to the SEC
FiledApr 30, 2026first sale Apr 6, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
John Mel SorensenExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.